**Author details**

Tania C. de Araujo-Jorge1 \*, Anna Cristina C. Carvalho1 , Roberto R. Ferreira1 , Luciana R. Garzoni1 , Beatriz M.S. Gonzaga1 , Marcelo T. Holanda2 , Gilberto M. Sperandio da Silva2 , Maria da Gloria Bonecini-Almeida<sup>3</sup> , Mauro F.F. Mediano2 , Roberto M. Saraiva<sup>2</sup> and Alejandro M. Hasslocher-Moreno2

1 Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (IOC), Rio de Janeiro, RJ, Brazil

2 Laboratory of Clinical Research in Chagas Disease, Evandro Chagas National Institute of Infectious Diseases (INI) at Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil

3 Laboratory of Immunology and Immunogenetic, Evandro Chagas National Institute of Infectious Diseases (INI) at Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil

\*Address all correspondence to: taniaaj@ioc.fiocruz.br

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
